Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSmall air bubbles in a Wegovy pre-filled pen are normal and do not mean the medicine is damaged or the dose will be lost. The bubble does not need to be removed before you inject. Semaglutide is delivered by a fixed-dose mechanism, and the presence of air inside the pen is an expected part of how it is manufactured and used. That said, it is worth understanding what you are looking at, because the right response depends on where the bubble is and what type of pen you are using. Wegovy is a prescription-only medicine; your prescriber and the Patient Information Leaflet that comes with your pen are your first reference for anything injection-related.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The biggest misunderstanding our prescribers hear most weeks is that a bubble in the Wegovy pen needs to be cleared the way you would prime an old-style syringe. It does not. Wegovy pens are not designed to be primed by the patient. The internal cartridge contains semaglutide solution alongside a small amount of air, which is placed there deliberately during filling to allow the piston to travel correctly. Attempting to flick or tap the pen to shift it, or pressing the dose button with the cap off in the hope of pushing air out, will eject a portion of your medicine and is likely to mean your next injection is short. The pen has no safety mechanism that replaces expelled dose.
This is one of those moments where the instinct to do something is exactly the wrong instinct. The NHS semaglutide medicines page and the Patient Information Leaflet both describe a straightforward injection process with no priming step. If the instructions in your leaflet do not mention priming, that is because it is not needed.
One concrete check: look at the solution through the viewing window. It should be clear and colourless. Cloudiness, particles or an unusual colour are reasons to contact your pharmacist and not inject. If you want to read more about what to expect visually, our page on air bubbles in the Wegovy pen explains what is normal and what is not, and a visible air bubble in otherwise clear solution is not a concern.
There are two distinct places a bubble might appear, and they are not the same situation. A bubble inside the cartridge, visible through the pen's inspection window, is the one described above: benign, leave it alone. If you have noticed your Wegovy pen has an air bubble and are unsure which part of the device it is in, identifying the location is the most useful first step. A bubble or droplet at the very tip of the needle, appearing after you attach the needle and remove the outer cap, is different and worth attention.
If liquid or a bubble appears at the needle tip before you have pressed the dose button, it usually means the needle was not attached squarely, or that a previous injection compressed the cartridge and left residual pressure. In that case, remove the needle carefully, dispose of it safely in a sharps container, attach a new needle, and proceed with your injection. A needle that arrives with liquid already at its tip has not been used to inject and should be replaced as a precaution rather than used.
After a successful injection, a small drop appearing at the needle tip is normal and does not indicate that any dose was lost, the dose counter will have moved regardless. If you are seeing bubbles in your Wegovy pen at this stage of the process, the detail on that page can help you work out whether what you are observing is expected. Remove the needle, cap the pen, and store it as directed. You do not need to account for that drop.
A correctly delivered Wegovy injection will see the dose button travel fully to the stop, the dose counter return to zero (or advance to the next number depending on pen design), and a click or resistance indicating the end of the injection. You are advised to keep the needle in the skin for six seconds after the button has fully depressed, then withdraw smoothly. If the counter did not change, or the button did not fully depress, do not attempt a second injection: contact your prescriber or pharmacist the same day.
Questions about whether a partial dose was delivered, or what to do about a missed injection, belong with a clinician rather than a forum. For context on how Wegovy fits into a broader weight-management plan and what the treatment involves, the Wegovy overview on the nume site covers the licensed indication, the titration schedule, and what to expect. If you are comparing the injection with other options, there is also a plain-language look at weight-loss treatments more broadly. For questions about where to store your pen, how to handle it during travel, or what happens if the pen has been left out of the fridge, the Patient Information Leaflet and your prescribing pharmacist are the right place to start, storage windows are product-specific and should not be generalised.
On the subject of air in semaglutide formulations more broadly, the guidance is consistent: air bubbles in semaglutide injections are covered in more detail if your question extends beyond the Wegovy pen specifically. The mechanism is the same across semaglutide-based products, but pen design can differ, so always match your technique to the leaflet for your specific device.
A functioning, correctly stored Wegovy pen from the licensed UK supply chain should present with clear solution and an intact seal. If your pen arrived with the outer seal already broken, with a needle pre-attached, or with cloudy or discoloured liquid, those are not bubble questions, they are reasons to contact the dispensing pharmacy immediately and not inject.
If you are sourcing Wegovy through a regulated UK pharmacy, you should be able to verify that pharmacy on the GPhC register. Pens obtained from unverified sellers, via social media, or from sources offering the medicine without a prescription carry a real risk of being counterfeit, the MHRA has warned publicly about fake weight-loss pens entering the UK supply, some of which have contained insulin rather than semaglutide. Our page on a bubble in the Wegovy pen addresses this context too, because understanding whether your pen is legitimate is part of making sense of anything unusual you notice. A pen from an unverified source is a different matter entirely.
If you have questions about your current prescription or want a clinical review before your next dose, our prescribers are available seven days a week. You can also browse common questions on the faqs page or reach the support team directly. For anyone not yet on treatment and weighing up their options, starting a free consultation is the first step toward a same-day clinical review by a GPhC-registered prescriber.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.